Grants and Contributions:
Title:
Development of a biologic for the treatment of diabetic macular edema
Agreement Number:
885836
Agreement Value:
$350,000.00
Agreement Date:
May 1, 2017 - Mar 29, 2019
Description:
A novel treatment that will offer a new alternative to poor responders of currrent therapies of diabetic macular edema.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Montreal-Ouest, Quebec, CA H4X 1Z5
Reference Number:
172-2018-2019-Q2-885836
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
748799525
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The total amended value is 50,000 dollars.
Amendment Date
Nov 9, 2018
Recipient's Legal Name:
Semathera Inc.
Federal Riding Name:
Notre-Dame-de-Grâce--Westmount
Federal Riding Number:
24053
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
54171
Amendments: